Company Legal Name
Latest Valuation
Founded Year
Headquarter
Raycaster operates an enterprise AI platform designed specifically for life sciences providers to accelerate regulatory and legal research processes. Operating under the legal entity 7th Ave Labs, Inc., the New York-based company delivers an all-in-one solution that streamlines complex compliance and legal workflows within the highly regulated life sciences sector. Founded in 2024, Raycaster addresses the critical need for faster, more efficient research capabilities in an industry where regulatory approval timelines directly impact market entry and revenue generation. The company is currently focused on expanding its AI-powered research capabilities and building market presence among pharmaceutical, biotechnology, and medical device companies.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





